This study explored the expression of MCP‐1 in breast tumour samples from a cohort of 251 Australian women with breast cancer and examined whether MCP‐1 expression is correlated with incidence of metastasis–termed distant relapse in this study–and survival. Here, CCL2 is linked to breast cancer.